Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

BACKGROUND: Intravenous methylprednisolone (IV-MP) is an established treatment for multiple sclerosis (MS) relapses, accompanied by rapid, though transient reduction of gadolinium enhancing (Gd+) lesions on brain MRI. Intermittent IV-MP, alone or with immunomodulators, has been suggested but insuffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Then Bergh, Florian, Kümpfel, Tania, Schumann, Erina, Held, Ulrike, Schwan, Michaela, Blazevic, Mirjana, Wismüller, Axel, Holsboer, Florian, Yassouridis, Alexander, Uhr, Manfred, Weber, Frank, Daumer, Martin, Trenkwalder, Claudia, Auer, Dorothee P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1501038/
https://www.ncbi.nlm.nih.gov/pubmed/16719908
http://dx.doi.org/10.1186/1471-2377-6-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1501038/
https://www.ncbi.nlm.nih.gov/pubmed/16719908
http://dx.doi.org/10.1186/1471-2377-6-19

Ejemplares similares